BioMimetic Therapeutics, Inc. Reports 2010 Third Quarter Earnings Results: Loss Per Share of $0.29

BioMimetic Therapeutics, Inc. BMTI today reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months ended September 30, 2010, the Company reported a net loss of $7.8 million, or $0.29 per diluted share, compared to a net loss of $7.9 million, or $0.36 per diluted share, for the same period in 2009. For the nine months ended September 30, 2010, the Company reported a net loss of $23.9 million, or $1.02 per diluted share, compared to a net loss of $22.3 million, or $1.11 per diluted share, for the same period in 2009. The Company ended the quarter with $99.4 million of cash and cash equivalents and investments.